What these compounds are, why most of the evidence is still preclinical, and what a doctor should be checking before anything is prescribed. Then compare clinics — free to enquire.
Recovery and tissue-repair programs draw on a mix of registered treatments and compounded peptides. Much of the peptide evidence here is preclinical — understand what is proven versus experimental before you start.
Injury recovery care covers a lot of ground: accurate diagnosis, physiotherapy and progressive loading, imaging where it changes the plan, registered anti-inflammatories, and — increasingly — compounded peptides marketed for tissue repair.
BPC-157, TB-500 and GHK-Cu sit in that last group. None has an ARTG-registered product in Australia. Their reputation rests largely on animal studies reporting accelerated tendon, ligament and gut-tissue healing; controlled human trials are scarce to non-existent.
That does not automatically make them fringe — plenty of medicine begins in animal models — but the honest description is experimental, and a clinic describing them as proven is overstating what has been published.
Meanwhile the unglamorous interventions still carry the strongest evidence for most soft-tissue injuries: getting the diagnosis right, progressive loading, sleep, adequate protein and time. A good clinic will say so before it says anything else.
Neutral descriptions of the compounds that come up under this goal, with their Australian regulatory position and the strength of the human evidence. Listed so you can follow the conversation — not so you can choose one.
No registered product anywhere. Published evidence is almost entirely animal studies; controlled human trials are very limited. Prohibited in sport under the WADA code.
Read the BPC-157 guideA synthetic fragment related to thymosin beta-4. Evidence is animal and laboratory data; there is no registered human product. Prohibited in sport under the WADA code.
Read the TB-500 guideBest studied as a topical compound in skin research. Injectable use for tissue repair is compounded and the evidence is early.
Several of these are prescription-only or compounded medicines. Listed for education only — a registered doctor decides what (if anything) is appropriate. Regulatory status changes over time; the ARTG and your prescriber are the current source of truth.
Ready to talk to someone?Compare 31 clinics listed under Injury Recovery below. Free to enquire, and only the clinic you choose receives your details.
See the clinicsClinics differ in how thoroughly they assess. Knowing the shape of a careful process makes it easier to tell one from the other.
Examination and, where it changes management, imaging. Treating the wrong structure is the most common reason a recovery stalls.
Any credible program is built around progressive loading and physiotherapy. Compounds, if they feature at all, sit alongside that rather than instead of it.
A prescriber should tell you plainly that the peptide evidence here is largely preclinical, and what that means for what you can reasonably expect.
A set timeframe and a concrete measure of progress — range of motion, load tolerance, pain scores — rather than an open-ended prescription.
These are the questions that separate a considered consultation from a transaction. You are entitled to ask every one of them, and to expect a straight answer.
This checklist is general information to help you prepare for an appointment. It is not medical advice and it is not a substitute for individual assessment by a registered practitioner.
There is no ARTG-registered BPC-157 product. Where it is lawfully supplied, it is on an individual prescription through a compounding pharmacy, and its regulatory status has been subject to review. Buying it online as a research chemical is not a lawful supply route.
In rodents, published studies report faster tendon and ligament healing. The controlled human trials that would confirm this are essentially absent, so describing it as proven in people is not supported by the literature.
They are different molecules studied in different animal models. BPC-157 derives from a gastric protein sequence; TB-500 is a synthetic fragment related to thymosin beta-4. Both are compounded rather than registered in Australia, and both are prohibited in sport.
It is the same molecule. Most published research is topical and dermatological. Injectable use aimed at tissue repair is a different application with much less evidence behind it.
BPC-157 and TB-500 are on the WADA prohibited list, and a prescription does not exempt a competing athlete without an approved therapeutic use exemption.
That is a question for the treating practitioner, but the evidence hierarchy is not close: accurate diagnosis and progressive loading are the interventions with the strongest support for soft-tissue injury.
Doctor-supervised clinics that list Injury Recovery as an area of care. Free to compare and free to enquire — only the clinic you choose receives your details.
Listings are information only. Verification confirms a clinic’s prescriber is registered with AHPRA — not an endorsement of treatment. Prescribing decisions are made solely by a registered practitioner. How we verify
A plain-English summary of what the published research on recovery peptides does and does not show, and how to test a clinic's claims against it.
Educational content only. No clinic receives your email from this form, and we never send prescribing or treatment recommendations. Unsubscribe anytime.
Information only, not medical advice. Get Enhanced is a directory. It does not prescribe, supply, endorse or recommend any medicine or treatment, and nothing on this page is an offer to supply a therapeutic good.
Prescribing decisions are made solely by a registered health practitioner following individual assessment. Compounds described above include prescription-only and compounded medicines; compounded preparations are not assessed by the TGA for quality, safety or efficacy in the way registered products are.
We check the AHPRA register — this is not an endorsement by AHPRA or of any treatment. Read the full medical disclaimer or how we verify clinics.
Want the science first? Start with the BPC-157 guide.